CS logo
small CS logo
Centrum Medyczne "Luxmed" Sp. z o.o.

Lublin, Poland
Medical center in Lublin
Radziwiłłowska 5, 20-080 Lublin

About Centrum Medyczne "Luxmed" Sp. z o.o.


"Centrum Medyczne Luxmed oferuje bardzo szeroki zakres usług medycznych. Lekarze pierwszego kontaktu, poradnie specjalistyczne, badania laboratoryjne, usg, rtg, badania prenatalne, bezpłatną opiekę medyczną dla studentów oraz abonamenty dla firm.Oferta centrum medycznego Luxmed Radziwiłłowska 5 to także usługi stomatologiczne z diagnostyką obrazową między innymi pantomogram 3D, ortodonta, gabinet higieny stomatologicznej"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Centrum Medyczne "Luxmed" Sp. z o.o.


During the past decade, Centrum Medyczne "Luxmed" Sp. z o.o. conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Centrum Medyczne "Luxmed" Sp. z o.o." #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Amgen" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 2 trials sponsored and "Adial Pharmaceuticals" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne "Luxmed" Sp. z o.o." #1 collaborator was "Novartis" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Centrum Medyczne "Luxmed" Sp. z o.o.


According to Clinical.Site data, the most researched conditions in "Centrum Medyczne "Luxmed" Sp. z o.o." are "Depressive Disorder, Major" (5 trials), "Schizophrenia" (3 trials), "Migraine" (2 trials), "Alcohol Use Disorder" (1 trials) and "Carcinoma" (1 trials). Many other conditions were trialed in "Centrum Medyczne "Luxmed" Sp. z o.o." in a lesser frequency.

Clinical Trials Intervention Types at Centrum Medyczne "Luxmed" Sp. z o.o.


Most popular intervention types in "Centrum Medyczne "Luxmed" Sp. z o.o." are "Drug" (14 trials), "Other" (3 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Erenumab Dose 1" (2 trials), "Erenumab Dose 2" (2 trials), "Erenumab Dose 3" (2 trials) and "Rapastinel" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Centrum Medyczne "Luxmed" Sp. z o.o.


The vast majority of trials in "Centrum Medyczne "Luxmed" Sp. z o.o." are 15 trials for "All" genders.

Clinical Trials Status at Centrum Medyczne "Luxmed" Sp. z o.o.


Currently, there are NaN active trials in "Centrum Medyczne "Luxmed" Sp. z o.o.". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Centrum Medyczne "Luxmed" Sp. z o.o., undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Medyczne "Luxmed" Sp. z o.o., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".